The Canadian government is stepping up efforts to rein in the cost of prescription drugs. At the start of this month, Canada proposed the first major update to the Patented Medicines Regulations in more than 20 years.
Mylan N.V. has received Food and Drug Administration approval for Ogivri (trastuzumab-dkst), a biosimilar oncology drug co-developed with Biocon Ltd.
CVS Health has released findings from a poll on flu immunization as it urges families to get their shots during National Influenza Vaccination Week with the approach of peak flu season. A recent CVS survey found that 61% of Americans get a flu vaccine every year or plan to get one this
Lannett Co. has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive U.S. distributor for metoprolol succinate extended-release tablets, a cardiovascular medication. Financial terms weren’t disclosed.
CVS Health has announced that its pharmacy benefits manager (PBM), CVS Caremark, will begin providing real-time visibility to member-specific medication costs and available lower-cost therapeutic alternatives at the point of prescribing and at the pharmacy.
Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is reorganizing its business and leadership structure.
Teva Pharmaceuticals USA has launched a U.S. prescription co-payment assistance program in the U.S. for its imatinib mesylate tablets, a cancer treatment.
PharmaSmart International Inc. welcomed new guidelines updating the definition of hypertension and stressing the use of validated devices for measuring blood pressure.
Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.
Merck has received approval for a new version of GONAL-f (follitropin alfa injection) prefilled pen from the U.S. Food and Drug Administration (FDA). Known as GONAL-f RFF Redi-ject prefilled pen in the U.S.
AstraZeneca plans to release Fasenra, its newly approved biologic drug for severe asthma, to U.S. pharmacies in the coming weeks.
Building on its efforts to fight the opioid abuse epidemic, Cardinal Health Inc. has launched an initiative targeting one of the nation’s hardest-hit areas.
Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov.
The Pharmacy Quality Alliance (PQA) has named new members to its board of directors and approved its 2018 executive committee. Mary Ann Kliethermes, vice chair of ambulatory care and professor at the Midwestern University Chicago College of Pharmacy, will serve as PQA’s chairman for 2018.
Health screening kiosk maker higi SH LLC welcomed reduced standards for high blood pressure (BP) released this week by the American Heart Association (AHA) and the American College of Cardiology (ACC).
